RECORD OF PROCEEDINGS
PHYSICAL DISABILITY BOARD OF REVIEW
NAME: XXXXXXXXXXXXXXX BRANCH OF SERVICE: ARMY
CASE NUMBER: PD1201559 DATE OF PLACEMENT ON TDRL: 20020225
BOARD DATE: 20130116 DATE OF PERMANENT SEPARATION: 20031105
SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this
covered individual (CI) was an active duty PFC/E-3 (13F10/Fire Support Specialist), medically
separated for asthma. The CI began having wheezing, shortness of breath, and chest tightness
during physical therapy (PT). He did not improve adequately with inhalational medications to
meet the physical requirements of his Military Occupational Specialty (MOS) or satisfy physical
fitness standards. He was issued a permanent P4 profile and referred for a Medical Evaluation
Board (MEB). Asthma was forwarded to the Physical Evaluation Board (PEB) as medically
unacceptable IAW AR 40-501. There were no other conditions on the MEB submission. The
PEB adjudicated the asthma condition as unfitting, rated 60%, with application of the Veterans
Affairs Schedule for Rating Disabilities (VASRD). However, the US Army Physical Disability
Agency (USAPDA) reviewed the case and recommended a 30% rating. The PEB changed the
rating to 30% and the CI was placed on Temporary Disability Retired List (TDRL). The CI was
reevaluated over a year later and the PEB adjudicated the asthma condition as unfitting, rated
10%, with application of the VASRD. The CI made no appeals, and was medically separated
with a 10% disability rating.
CI CONTENTION: Asthma (My rating was 30%) This conditions [sic] limits my abilities
tremendously. I couldnt make an appointment and never knew how to get another one and
get help. I also lost my.
SCOPE OF REVIEW: The Board wishes to clarify that the scope of its review as defined in DoDI
6040.44, Enclosure 3, paragraph 5.e.(2) is limited to those conditions which were determined
by the PEB to be specifically unfitting for continued military service; or, when requested by the
CI, those condition(s) identified but not determined to be unfitting by the PEB. The ratings
for unfitting conditions will be reviewed in all cases. The asthma condition requested for
consideration meets the criteria prescribed in DoDI 6040.44 for Board purview, and is
accordingly addressed below. Any condition or contention not requested in this application, or
otherwise outside the Boards defined scope of review, remain eligible for future consideration
by the Army Board for Correction of Military Records.
TDRL RATING COMPARISON:
Service IPEB Dated 20030902
VA All Effective Date 20060424
Condition
Code
Rating
Condition
Code
Rating
Exam
On TDRL
20011019
TDRL
Sep.
Asthma
6602
30%
10%
Asthma
6602
0%*
20060830
No Additional MEB/PEB Entries
Combined: 10%
Combined: 0%*
*VA rated 0% because the CI did not report for his C&P exam on 20060830.
ANALYSIS SUMMARY: The Board acknowledges the sentiment expressed in the CIs application
regarding the significant impairment with which his service-incurred condition continues to
burden him. The Board wishes to clarify that it is subject to the same laws for disability
entitlements as those under which the Disability Evaluation System (DES) operates. The DES
has neither the role nor the authority to compensate members for anticipated future severity
or potential complications of conditions resulting in medical separation. That role and
authority is granted by Congress to the Department of Veterans Affairs (DVA), operating under
a different set of laws (Title 38, United States Code). The Board evaluates DVA evidence
proximal to separation in arriving at its recommendations, but its authority resides in evaluating
the fairness of DES fitness decisions and rating determinations for disability at the time of
separation. While the DES considers all of the member's medical conditions, compensation can
only be offered for those medical conditions that cut short a members career, and then only to
the degree of severity present at the time of final disposition. The DVA, however, is
empowered to compensate service-connected conditions and to periodically re-evaluate said
conditions for the purpose of adjusting the Veterans disability rating should the degree of
impairment vary over time.
Asthma Condition. The MEB narrative summary (NARSUM) in June 2001, 8 months prior to
TDRL-entry, cited the pulmonary function test (PFT) in December 2000. That PFT showed a pre-
bronchodilator FEV-1 of 55% predicted and FEV-1/FVC of 44%, upon which the PEB based its
rating of 60% for code 6602. The USAPDA returned the case and the PEB rating was changed to
30% by applying, instead, the post-bronchodilator PFT results. There was no VA exam
proximate either to entry into TDRL or at exit from TDRL. The TDRL NARSUM in July 2003, 4
months before TDRL-exit, reported results of a PFT in May 2003 which showed a pre-
medication FEV-1 of 58% predicted and an FEV-1/FVC of 62.8%. The CI reported that he used
inhaler medication daily, as well as weekly rescue inhalers. The PEB, citing far less than daily
use of inhalational medications based on the available pharmacy records, assigned a final
rating of 10%.
Pulmonary Exam
MEB ~30 Mo. Pre-Sep
TDRL Eval ~4 Mo. Pre-Sep
Pre-Med
Post-Med
Pre-Med
Post-Med
FEV-1 (% Predicted)
55
67
58
10% better
FEV-1/FVC (%)
44
56
62.8
10% better
Meds
Flovent, Singulair, Serevent,
& Albuterol avg 4x/day
Albuterol, Salmeterol, and Flovent
(see text)
§4.97 Rating
30%
30% (PEB 10%)
The Board directs attention to its rating recommendation based on the above evidence. The
TDRL-entry rating of 30% was supported by all of the data. There were no hospitalizations or
courses of systemic corticosteroids to support a higher rating. VASRD guidance in effect at that
time matched the former DoDI language for post-bronchodilator PFT use for ratings and mirrors
the current VASRD §4.96 provisions added in 2006. The PEB at TDRL-exit rated the asthma
condition at 10% based on available pharmacy records, which indicated less than daily
medication use. However, the PFT results cited in the TDRL NARSUM were within the rating
criteria range for 30%, for both FEV-1 and FEV-1/FVC, as charted above; the estimated 10%
better results with pre-treatment were still within the 56-70% criteria for a 30% rating. The
Board also discussed the use of daily controller medications by prescription requirement and
NARSUM statement versus medication profile, but the PFTs alone supported the 30% rating.
After due deliberation, considering all of the evidence and mindful of VASRD §4.3 (reasonable
doubt), the Board recommends a final TDRL exit rating of 30% for the asthma condition.
BOARD FINDINGS: IAW DoDI 6040.44, provisions of DoD or Military Department regulations or
guidelines relied upon by the PEB will not be considered by the Board to the extent they were
inconsistent with the VASRD in effect at the time of the adjudication. In the matter of the
asthma condition, the Board unanimously recommends a a permanent disability rating of 30%,
coded 6602, IAW VASRD §4.97. There were no other conditions within the Boards scope of
review for consideration.
RECOMMENDATION: The Board recommends that the CIs prior determination be modified as
follows; TDRL entry at 30%, and, that the discharge with severance pay be recharacterized to
reflect permanent disability retirement, effective as of the date of his prior medical separation:
UNFITTING CONDITION
VASRD CODE
RATING
PERMANENT
Asthma
6602
30%
COMBINED
30%
The following documentary evidence was considered:
Exhibit A. DD Form 294, dated 20120808, w/atchs
Exhibit B. Service Treatment Record
Exhibit C. Department of Veterans Affairs Treatment Record
xxxxxxxxxxxxxxxxxxxxxx, DAF
Acting Director
Physical Disability Board of Review
SFMR-RB
MEMORANDUM FOR Commander, US Army Physical Disability Agency
(TAPD-ZB / xxxxxxxxxxxx), 2900 Crystal Drive, Suite 300, Arlington, VA 22202-3557
SUBJECT: Department of Defense Physical Disability Board of Review Recommendation
for xxxxxxxxxxxxxxxxxxxx, AR20130007476 (PD201201559)
1. Under the authority of Title 10, United States Code, section 1554(a), I approve the
enclosed recommendation of the Department of Defense Physical Disability Board of
Review (DoD PDBR) pertaining to the individual named in the subject line above to
recharacterize the individuals separation as a permanent disability retirement with the
combined disability rating of 30% effective the date of the individuals original medical
separation for disability with severance pay.
2. I direct that all the Department of the Army records of the individual concerned be
corrected accordingly no later than 120 day suspense date:
a. Providing a correction to the individuals separation document showing that
the individual was separated by reason of permanent disability retirement effective the
date of the original medical separation for disability with severance pay.
b. Providing orders showing that the individual was retired with permanent
disability effective the date of the original medical separation for disability with
severance pay.
c. Adjusting pay and allowances accordingly. Pay and allowance adjustment will
account for recoupment of severance pay, and payment of permanent retired pay at
30% effective the date of the original medical separation for disability with severance
pay.
d. Affording the individual the opportunity to elect Survivor Benefit Plan (SBP)
and medical TRICARE retiree options.
3. I request that a copy of the corrections and any related correspondence be provided
to the individual concerned, counsel (if any), any Members of Congress who have
shown interest, and to the Army Review Boards Agency with a copy of this
memorandum without enclosures.
BY ORDER OF THE SECRETARY OF THE ARMY:
Encl xxxxxxxxxxxxxxxxxxxxxxx
Deputy Assistant Secretary
(Army Review Boards)
AF | PDBR | CY2011 | PD 2011 01084
TDRL Rating Chart Final Service IPEB Dated 20021001 VA All Effective Date 20030911 Condition Code Rating Condition Code Rating Exam On TDRL 20010813 TDRL Sep. Asthma 6602 30% 0% Asthma 6602 30%* 20031023 .No Additional MEB/PEB Entries. The PEB rated the condition as 6602 asthma, bronchial and assigned a 30% disability stating the asthma condition was only moderately controlled on multiple medications, including daily inhaled anti-inflammatory aerosols. RECOMMENDATION: The Board...
AF | PDBR | CY2012 | PD2012-00469
The CI was re-evaluated almost 14 months later and the PEB recommended removal of the CI from the TDRL with a permanent disability rating of 10%. The PEB initially utilized VASRD code 6602, asthma, and rated it 30% based on daily inhaled medications with normal PFTs and placed the CI on TDRL. I direct that all the Department of the Army records of the individual concerned be corrected accordingly no later than 120 days from the date of this memorandum: individual was separated by reason of...
AF | PDBR | CY2013 | PD-2013-01964
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVeterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at the time of separation. He requires close medical follow-up, and consideration should be given to TDRL status.”On 4 January 2004, the CI was placed on the TDRL with a rating of 60%. The CI’s asthma was not severe enough to justify a higher...
AF | PDBR | CY2012 | PD 2012 00492
Asthma. In the matter of the asthma condition and IAW VASRD §4.97, the Board unanimously recommends no change in the PEB adjudication at either the time of TDRL entry or at the time of TDRL exit and permanent separation from service. RECOMMENDATION: The Board, therefore, recommends that there be no recharacterization of the CIs disability and separation determination, as follows: UNFITTING CONDITION VASRD CODE RATING TDRL PERMANENT Asthma 6602 30% 0% COMBINED 30% 0% The following...
AF | PDBR | CY2012 | PD2012 01210
No other conditions were submitted by the MEB.The PEB adjudicated asthma with VCDand chronic pain left knee conditions as unfitting, rated 30% and 0% respectively,referencing the US Army Physical Disability Agency (USAPDA) pain policy. 660230%10%Asthma with Vocal Cord Dysfunction660230%20020606Chronic Pain, Left Knee In addition, the CI had a VCD that significantly responded to the beta-agonist inhalational medication, Albuterol for which the medication profile in evidence reflects dosing...
AF | PDBR | CY2009 | PD2009-00263
The PEB’s DA Form 199 dated 20050413 indicated “Asthma, with normal spirometry, on intermittent inhalational bronchodilator therapy.” The PEB specified “Medication profile shows no controller medication between March – April 2004 and 15 February 2005.” The PEB permanent separation rating was 6602 at 10%; and the VASRD 10% criteria contains the phrasing “intermittent inhalational or oral bronchodilator therapy.” There is therefore no evidence that the provisions of DoDI 1332.39 were applied. ...
AF | PDBR | CY2012 | PD 2012 00734
Post-Separation) Effective 20020807 Condition Code Rating Condition Code Rating Exam Asthma 6602 10% Asthma 6602 10%* 20030114 .No Additional MEB/PEB Entries. Both the Army PEB and the VA coded the asthma condition 6602, and rated it 10%. RECOMMENDATION: The Board, therefore, recommends that there be no recharacterization of the CIs disability and separation determination, as follows: UNFITTING CONDITION VASRD CODE RATING Asthma 6602 10% COMBINED 10% The following documentary evidence...
AF | PDBR | CY2013 | PD2013 01583
In addition, the CI was notified by the Service that his case qualifies for review of his mental health (MH) condition in accordance with the Secretary of Defense directive for a comprehensive review of Service members who were referred to a disability evaluation process between 11 September 2001 and 30 April 2012 and whose MH diagnoses were unfavorably changed or eliminated during that process. Accordingly, the case file was reviewed regarding unfavorable diagnosis change, fitness...
AF | PDBR | CY2014 | PD-2014-03148
Both the Air Force PEB and the VA coded the pulmonary condition 6602 (Asthma). The PEB rated it 10%, and the VA rated it 30%. Eight months later, she was using the anti-inflammatory corticosteroid Motametasone.Following a thorough review of the evidence in the treatment record, the Board concluded that it was more likely than not that the CI was using inhalational anti-inflammatory medication at the time of separation from service.
AF | PDBR | CY2013 | PD-2013-02236
In December 2004 theMEB found the asthma condition had stabilized sufficiently and the PEB adjudicated “exertion asthma” unfitting, rated at 10% disability and the CI was removed from the TDRL on 30 December 2004. The Board deliberated if the TDRL NARSUM current medications’listing oral Singulair was supported by the record and if it met the VASRD 6602 30% rating criteria for daily oral bronchodilator therapy.The Board discussed the evidence of record concerning Singulair use.Singulair was...